AC-13725 - lidocaine-975 | 137-58-6
Lo sentimos, no se ha encontrado ningún producto con referencia AC-13725, pero quizás quiera comprobar los siguientes productos similares:
Lidocaine
CAS:Fórmula:C14H22N2OPureza:>99.0%(T)(HPLC)Forma y color:White to Almost white powder to crystalPeso molecular:234.34Lidocaine
CAS:LidocaineFórmula:C14H22N2OPureza:100.0%Forma y color:White To Off-WhitePeso molecular:234.17321Lidocaine
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H22N2OForma y color:White Off-White Crystalline PowderPeso molecular:234.34Lidocaine
CAS:Lidocaine, an amide local anesthetic, reduces pain and inflammation by dampening ICAM-1, cytokines, and neutrophil influx.Fórmula:C14H22N2OPureza:99.95% - >99.99%Forma y color:Needles From Benzene Or Alcohol SolidPeso molecular:234.34Lidocaine
CAS:Fórmula:C14H22N2OPureza:≤ 0.1%Forma y color:White crystalline powderPeso molecular:234.34Lidocaine
CAS:Lidocaine is a local anesthetic drug that blocks the transmission of nerve impulses, which prevents pain in the area where it is applied. Lidocaine is used to treat many different types of pain and it has been shown to be effective in reducing systolic pressure. Lidocaine may also be used as a vasopressor agent or to maintain blood pressure during surgery. The use of lidocaine is contraindicated in cases of cardiac arrhythmia, myocardial infarction, or congestive heart failure. Lidocaine can cause neuronal death at high concentrations and various combinations have been developed to reduce this risk. Lidocaine topical preparations are available for nasal administration and can be used as an adjunct therapy for chronic rhinosinusitis with nasal polyps. Lidocaine has been shown to inhibit toll-like receptor 4 (TLR4) signaling pathways in vivo models, which may contribute to its ability to suppress the developmentFórmula:C14H22N2OPureza:Min. 95%Forma y color:PowderPeso molecular:234.34 g/mol
